![""](/research/silverman-lab/sites/default/files/styles/fixed_height_250_1600w_320h/public/2023-03/silverman-lab-publications-hero.jpg?h=2c7ac911&itok=unT-d-eG)
B-cell Immunobiology Lab Publications
Read the latest papers published by investigators in NYU Langone’s B-cell Immunobiology Lab.
Recent Publications
Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination
Annals of clinical and translational neurology. 2024 May 07;
The gut microbiome in systemic lupus erythematosus: lessons from rheumatic fever
Nature reviews. Rheumatology. 2024 Mar ; 20:143-157
Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination
Annals of Clinical and Translational Neurology. 2024 Jan 01; ?-?
Understanding the roles of the microbiome in autoimmune rheumatic diseases
Rheumatology and Immunology Research. 2023 Dec 01; 4:177-187
Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares
Annals of the rheumatic diseases. 2023 Oct ; 82:1315-1327
Pharmacologic inhibition of glycolysis prevents the development of lupus by altering the gut microbiome in mice
iScience. 2023 Jul 21; 26:107122
American journal of respiratory & critical care medicine. 2023; A6281-A6281
Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapies
Annals of clinical & translational neurology. 2022 Oct ; 9:1643-1659